{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:05:11Z","timestamp":1771646711942,"version":"3.50.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,15]]},"DOI":"10.2169\/internalmedicine.5786-25","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:09:04Z","timestamp":1753913344000},"page":"552-556","source":"Crossref","is-referenced-by-count":0,"title":["Drug-induced Pleuritis Associated with Hachimijiogan"],"prefix":"10.2169","volume":"65","author":[{"given":"Keisuke","family":"Kuroda","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Tottori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Nakazaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tottori Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Shibata","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Heffner JE, Highland K, Brown LK. A meta-analysis derivation of continuous likelihood ratios for diagnosing pleural fluid exudates. Am J Respir Crit Care Med 167: 1591-1599, 2003.","DOI":"10.1164\/rccm.200301-048PP"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Huggins JT, Sahn SA. Drug-induced pleural disease. Clin Chest Med 25: 141-153, 2004.","DOI":"10.1016\/S0272-5231(03)00125-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Morelock SY, Sahn SA. Drugs and the pleura. Chest 116: 212-221, 1999.","DOI":"10.1378\/chest.116.1.212"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimada Y, Fujimoto M, Nogami T, Watari H. Adverse events associated with ethical Kampo formulations: analysis of the domestic adverse-event data reports of the Ministry of Health, Labor, and Welfare in Japan. Evid Based Complement Alternat Med 2019: 1643804, 2019.","DOI":"10.1155\/2019\/1643804"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Brixey AG, Light RW. Pleural effusions due to dasatinib. Curr Opin Pulm Med 16: 351-356, 2010.","DOI":"10.1097\/MCP.0b013e328338c486"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hawatmeh A, Thawabi M, Jmeian A, Shaaban H, Shamoon F. Amiodarone-induced loculated pleural effusion without pulmonary parenchymal involvement: a case report and literature review. J Nat Sci Biol Med 8: 130-133, 2017.","DOI":"10.4103\/0976-9668.198345"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bullington W, Sahn SA, Judson MA. Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Am J Med Sci 333: 290-292, 2007.","DOI":"10.1097\/MAJ.0b013e31805339ae"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Yoshida H, Hasegawa R, Hayashi H, Irie Y. Imidapril-induced eosinophilic pleurisy. Case report and review of the literature. Respiration 72: 423-426, 2005.","DOI":"10.1159\/000086259"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Smith PR, Nacht RI. Drug-induced lupus pleuritis mimicking pleural space infection. Chest 101: 268-269, 1992.","DOI":"10.1378\/chest.101.1.268"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Elkholy KO, Akhtar H, Chakraborti A. A case of seronegative ANA hydralazine-induced lupus presenting with pericardial effusion and pleural effusion. Cureus 12: e9831, 2020.","DOI":"10.7759\/cureus.9831"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vedove CD, Del Giglio MD, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res 301: 99-105, 2009.","DOI":"10.1007\/s00403-008-0895-5"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59: 809-820, 2004.","DOI":"10.1111\/j.1398-9995.2004.00547.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Spagnolo P, Bonniaud P, Rossi G, Sverzellati N, Cottin V. Drug-induced interstitial lung disease. Eur Respir J 60: 2102776, 2022.","DOI":"10.1183\/13993003.02776-2021"},{"key":"14","unstructured":"14. Inoue T, Tanaka E, Sakuramoto M, et al. A case of drug-induced pleuritis, possibly due to Hochuekkito. Nihon Kokyuki Gakkai Zasshi (Ann Jpn Respir Soc) 45: 258-261, 2007 (in Japanese, Abstract in English)."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Roberts ME, Rahman NM, Maskell NA, et al.; the BTS Pleural Guideline Development Group. British Thoracic Society Guideline for pleural disease. Thorax 78 (Suppl 3): s1-s42, 2023.","DOI":"10.1136\/thorax-2022-219784"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Deschuyteneer EP, De Keukeleire TD. Diagnostic value and safety of thoracoscopic pleural biopsies in pleural exudative effusions of unknown origin, including follow-up. BMJ Open Respir Res 9: e001161, 2022.","DOI":"10.1136\/bmjresp-2021-001161"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Evison M, Holme J, Alaloul M, et al. Olanzapine-induced eosinophilic pleuritis. Respir Med Case Rep 14: 24-26, 2015.","DOI":"10.1016\/j.rmcr.2014.11.007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cudzilo C, Aragaki A, Guitron J, Benzaquen S. Methotrexate-induced pleuropericarditis and eosinophilic pleural effusion. J Bronchology Interv Pulmonol 21: 90-92, 2014.","DOI":"10.1097\/LBR.0000000000000031"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hase I, Yamaguchi B, Takizawa H, et al. Pirfenidone-induced eosinophilic pleurisy. Intern Med 56: 1863-1866, 2017.","DOI":"10.2169\/internalmedicine.56.7738"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_5786-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:43:07Z","timestamp":1771645387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/4\/65_5786-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5786-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"article-number":"5786-25"}}